Stadius Biopharma LLC

[Available On-Demand]
Stadius Biopharma is an early stage biopharma company working to deliver novel, transformational monoclonal antibody therapeutics for the treatment of life threatening infectious diseases to treat opportunistic pathogens in immuno-compromised patients.
Company Type:
Company Website:
Company HQ State:
Louisiana
Company HQ Country:
United States
Year Founded:
2020
Main Therapeutic Focus:
Lead Product in Development:
Monoclonal antibodies to Candida spp and Asergillum
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
2
Speaker
photo
Acting Chief Executive Officer and Chief Scientific Officer
Stadius Biopharma LLC